-
<![CDATA[Belzutifan Maintains High, Durable Responses in VHL Disease–Associated Neoplasms At 5 Years]]>
06 Dec 2025 03:57 GMT
… inhibitor belzutifan in von Hippel-Lindau disease–associated neoplasms. … cancers associated with von Hippel-Lindau disease. News release. … von-hippel-lindau-disease
Srinivasan R, Iliopoulos O, Beckermann KE, et al. Belzutifan for von Hippel-Lindau disease …
-
<![CDATA[Belzutifan Demonstrates Promise in Von Hippel-Lindau Disease]]>
10 Nov 2025 20:35 GMT
… in patients with advanced von Hippel-Lindau (VHL) disease.1
A specialized … procedures. This suggests accelerated disease progression without belzutifan.
During … Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors – a …
-
Canada's $1.5-billion Rare Disease Drug Strategy generating 'return on investment' for patients and society but more needs to be done
26 Nov 2025 14:47 GMT
… defect leading to kidney damage
Von Hippel-Lindau (VHL) disease: A condition causing multiple … Oxlumo a "life-changing medication." As a result, her … health policy and a healthcare system that works for those with rare disorders …
-
Rare Neurological Disease Treatment Market Expands Across USA, Europe, APAC & Saudi Arabia to 2035
07 Nov 2025 12:35 GMT
… advancements in precision medicine, gene therapy, … .
Rare neurological disorders, while individually uncommon … approved Belzutifan for Von Hippel-Lindau disease, marking a milestone … Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals …
-
Management of Von Hippel-Lindau Syndrome
10 Jul 2025 10:39 GMT
… . Tadross is a fourth-year medical student at the University of … Miami Miller School of Medicine. Dr. Williams is an associate … . Solitary retinal capillary hemangioma: Hereditary (von Hippel-Lindau disease) or nonhereditary? Arch Ophthalmol 2001 …
-
Disease Monitoring and Treatment Patterns of von Hippel-Lindau Disease-Associated Renal Cell Carcinoma in the United States.
06 May 2025 14:09 GMT
Patients with von Hippel-Lindau (VHL) disease are predisposed to … . This study evaluated disease monitoring and treatment patterns … drug use, disease monitoring procedures, and medical specialist visits in … .61]), and visited more medical specialists (1.82 [95% …
-
Longitudinal Evaluation of Clear-cell Renal Cell Carcinoma in von Hippel-Lindau Disease.
28 Apr 2025 07:13 GMT
… understanding the natural history of von Hippel-Lindau (VHL) disease-associated renal cell carcinoma … of surgery, including chronic kidney disease (CKD), and mortality. Radiographic … patients, with high rates of disease progression, surgery, and metastasis …
-
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study.
16 Apr 2025 13:30 GMT
… belzutifan as systemic treatment for von Hippel-Lindau disease-associated renal cell carcinoma.
… of the National Institutes of Health, National Cancer Institute Center … Boston, MA, USA., Vanderbilt University Medical Center, Nashville, TN, USA., University …
-
China NMPA approves Merck's Welireg to treat adult patients with certain types of von Hippel─Lindau disease─associated tumours
23 Nov 2024 10:12 GMT
… Canada, announced that the National Medical Products Administration (NMPA) in China … and in combination with other medicines.
LITESPARK-004 is an open … and CNS hemangioblastomas.
Von Hippel-Lindau disease is a rare genetic disease that impacts an …
-
Pathogenicity of germline VHL variants is associated with renal cell carcinoma size in von Hippel-Lindau disease.
14 Feb 2025 15:07 GMT
… -phenotype correlations in patients with Von Hippel-Lindau (VHL) disease.
We retrospectively studied 53 … , Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo … , Hospital das Clínicas, Faculdade de Medicina da Universidade de São Paulo …
About
© 1995-2025